3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
2
Plasma cell
1
Conditions
Multiple Myeloma
84
Lymphoma, Non-Hodgkin
28
Hodgkin Disease
20
Neoplasms, Plasma Cell
18
Myelodysplastic Syndromes
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Leukemia, Myeloid, Acute
13
Lymphoma
11
Leukemia
10
Myeloproliferative Disorders
8
Lymphoma, Follicular
8
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Burkitt Lymphoma
8
Lymphoma, Mantle-Cell
7
Lymphoma, Large-Cell, Immunoblastic
7
Lymphoma, Large B-Cell, Diffuse
6
Blast Crisis
6
Primary Myelofibrosis
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myeloid, Chronic-Phase
5
Immunoglobulin Light-chain Amyloidosis
5
Congenital Abnormalities
5
Recurrence
4
Lymphoma, T-Cell, Cutaneous
4
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
4
Hematologic Neoplasms
4
Paraproteinemias
3
Leukemia, Myeloid, Accelerated Phase
3
Interventions
Tacrolimus
4
Epoetin Alfa
4
Busulfan
4
fludarabine
3
Darbepoetin alfa
3
Bortezomib
3
fludarabine phosphate
2
dacetuzumab
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Lenalidomide
2
Early Intervention, Educational
2
Dexamethasone
2
Antilymphocyte Serum
2
Alemtuzumab
2
venetoclax
1
trametinib
1
ruxolitinib
1
plerixafor
1
isatuximab
1
ficlatuzumab
1
ferrous sulfate
1
ferric gluconate
1
ethanolamine oleate
1
dabrafenib
1
Vorinostat
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Trimethoprim
1
Tinzaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoproliferative Disorders
×
Granulocyte Colony-Stimulating Factor
×
Plasma cell
×
Clear all
NCT01186224
2025-03-17
PHANTASTIC
University of Liverpool
Phase NA
Completed
60 enrolled